Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UB-621 for Recurrent Genital HSV-2 Infection
NCT03595995Phase 2Unknown
- Sponsor
- United BioPharma
- Start
- Jun 2023
- Primary completion
- Jun 2024
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of UB-621 in genital herpes, sponsored by United BioPharma. Status: unknown.
02
Drugs
UB-621
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT03595995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03595995.